AsiaMedic Limited (SGX:505)
Singapore
· Delayed Price · Currency is SGD 0.0190
0.00 (0.00%)
At close: Mar 6, 2026
AsiaMedic Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 35.22 | 28.91 | 23.6 | 18.88 | 18.26 | Upgrade
|
| Other Revenue | 0.82 | 0.17 | 0.15 | 0.16 | 0.17 | Upgrade
|
| Revenue | 36.04 | 29.09 | 23.75 | 19.04 | 18.42 | Upgrade
|
| Revenue Growth (YoY) | 23.91% | 22.46% | 24.72% | 3.38% | 19.81% | Upgrade
|
| Cost of Revenue | 25.89 | 23.28 | 18.4 | 14.78 | 14.25 | Upgrade
|
| Gross Profit | 10.15 | 5.8 | 5.35 | 4.27 | 4.17 | Upgrade
|
| Selling, General & Admin | 1.48 | 0.12 | 0.11 | 0.14 | 0.14 | Upgrade
|
| Other Operating Expenses | 4.23 | 2.56 | 2.45 | 2.15 | 1.97 | Upgrade
|
| Operating Expenses | 9.08 | 5.16 | 4.63 | 3.34 | 3.38 | Upgrade
|
| Operating Income | 1.06 | 0.65 | 0.72 | 0.92 | 0.79 | Upgrade
|
| Interest Expense | -0.91 | -0.59 | -0.42 | -0.24 | -0.15 | Upgrade
|
| Interest & Investment Income | - | 0.17 | 0.17 | 0.04 | 0.02 | Upgrade
|
| Earnings From Equity Investments | -0.63 | 0.32 | 0.44 | 0.48 | 0.36 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0.02 | - | - | 0.09 | Upgrade
|
| EBT Excluding Unusual Items | -0.48 | 0.57 | 0.91 | 1.21 | 1.12 | Upgrade
|
| Impairment of Goodwill | - | -0.05 | - | -0.52 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.91 | - | - | - | - | Upgrade
|
| Asset Writedown | - | 0.12 | 0.12 | 1.5 | -0.86 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.45 | Upgrade
|
| Pretax Income | 1.43 | 0.64 | 1.03 | 2.19 | 0.72 | Upgrade
|
| Income Tax Expense | - | -0 | -0.89 | - | - | Upgrade
|
| Earnings From Continuing Operations | 1.43 | 0.65 | 1.92 | 2.19 | 0.72 | Upgrade
|
| Minority Interest in Earnings | 0.59 | 0.36 | - | - | - | Upgrade
|
| Net Income | 2.02 | 1.01 | 1.92 | 2.19 | 0.72 | Upgrade
|
| Net Income to Common | 2.02 | 1.01 | 1.92 | 2.19 | 0.72 | Upgrade
|
| Net Income Growth | 100.45% | -47.44% | -12.13% | 205.72% | - | Upgrade
|
| Shares Outstanding (Basic) | 1,124 | 1,155 | 1,132 | 1,120 | 1,120 | Upgrade
|
| Shares Outstanding (Diluted) | 1,124 | 1,155 | 1,132 | 1,120 | 1,120 | Upgrade
|
| Shares Change (YoY) | -2.61% | 1.97% | 1.13% | - | 2.36% | Upgrade
|
| EPS (Basic) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| EPS Growth | 107.14% | -48.76% | -13.11% | 225.88% | - | Upgrade
|
| Free Cash Flow | 1.2 | 0.68 | 0.98 | 0.23 | 3.06 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | 0.00 | 0.00 | - | 0.00 | Upgrade
|
| Gross Margin | 28.16% | 19.95% | 22.52% | 22.40% | 22.65% | Upgrade
|
| Operating Margin | 2.95% | 2.22% | 3.03% | 4.85% | 4.31% | Upgrade
|
| Profit Margin | 5.62% | 3.47% | 8.09% | 11.48% | 3.88% | Upgrade
|
| Free Cash Flow Margin | 3.34% | 2.32% | 4.14% | 1.23% | 16.60% | Upgrade
|
| EBITDA | 1.96 | 1.34 | 1.6 | 1.19 | 1.17 | Upgrade
|
| EBITDA Margin | 5.43% | 4.59% | 6.74% | 6.24% | 6.35% | Upgrade
|
| D&A For EBITDA | 0.89 | 0.69 | 0.88 | 0.27 | 0.38 | Upgrade
|
| EBIT | 1.06 | 0.65 | 0.72 | 0.92 | 0.79 | Upgrade
|
| EBIT Margin | 2.95% | 2.22% | 3.03% | 4.85% | 4.31% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.